Literature DB >> 28937573

Committee Opinion No. 721: Smoking Cessation During Pregnancy.

.   

Abstract

Smoking is the one of the most important modifiable causes of poor pregnancy outcomes in the United States, and is associated with maternal, fetal, and infant morbidity and mortality. The physical and psychologic addiction to cigarettes is powerful; however, the compassionate intervention of the obstetrician-gynecologist can be the critical element in prenatal smoking cessation. An office-based protocol that systematically identifies pregnant women who smoke and offers treatment or referral has been proved to increase quit rates. A short counseling session with pregnancy-specific educational materials and a referral to the smokers' quit line is an effective smoking cessation strategy. The 5A's is an office-based intervention developed to be used under the guidance of trained practitioners to help pregnant women quit smoking. Knowledge of the use of the 5A's, health care support systems, and pharmacotherapy add to the techniques providers can use to support perinatal smoking cessation. The use of alternative forms of nicotine, such as e-cigarettes and vaping, have increased substantially in recent years, but there are little data regarding the health effects of these agents, either in the general population or in pregnant women specifically.

Entities:  

Mesh:

Year:  2017        PMID: 28937573     DOI: 10.1097/AOG.0000000000002353

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

1.  Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being.

Authors:  Kristin Ashford; Amanda Fallin-Bennett; Andrea McCubbin; Amanda Wiggins; Sheila Barnhart; Josh Lile
Journal:  Neurotoxicol Teratol       Date:  2019-03-29       Impact factor: 3.763

Review 2.  Electronic nicotine delivery systems and pregnancy: Recent research on perceptions, cessation, and toxicant delivery.

Authors:  Alison Breland; Andrea McCubbin; Kristin Ashford
Journal:  Birth Defects Res       Date:  2019-07-31       Impact factor: 2.344

Review 3.  Reducing tobacco use among women of childbearing age: Contributions of tobacco regulatory science and tobacco control.

Authors:  Allison N Kurti
Journal:  Exp Clin Psychopharmacol       Date:  2019-12-19       Impact factor: 3.157

4.  Sudden infant death and social justice: A syndemics approach.

Authors:  Melissa Bartick; Cecília Tomori
Journal:  Matern Child Nutr       Date:  2018-08-23       Impact factor: 3.092

5.  Estimating the effect of Prenatal Care Coordination in Wisconsin: A sibling fixed effects analysis.

Authors:  David C Mallinson; Andrea Larson; Lawrence M Berger; Eric Grodsky; Deborah B Ehrenthal
Journal:  Health Serv Res       Date:  2019-11-07       Impact factor: 3.402

6.  Impact of electronic nicotine delivery systems and other respondent characteristics on tobacco use transitions among a U.S. national sample of women of reproductive age.

Authors:  Allison N Kurti; Janice Y Bunn; Katherine Tang; Tyler Nighbor; Diann E Gaalema; Victoria Coleman-Cowger; Sulamunn R M Coleman; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2019-12-10       Impact factor: 4.492

Review 7.  Smoking and pregnancy: The era of electronic nicotine delivery systems.

Authors:  Nikita Desai
Journal:  Obstet Med       Date:  2020-01-21

8.  Urban-Rural Infant Mortality Disparities by Race and Ethnicity and Cause of Death.

Authors:  Lindsay S Womack; Lauren M Rossen; Ashley H Hirai
Journal:  Am J Prev Med       Date:  2019-11-15       Impact factor: 5.043

9.  Smoke-Free Moms: Financial Rewards for Smoking Cessation by Low-Income Rural Pregnant Women.

Authors:  Ardis L Olson; Maureen B Boardman; Deborah J Johnson
Journal:  Am J Prev Med       Date:  2019-04-17       Impact factor: 5.043

10.  Co-use of tobacco and marijuana during pregnancy: Pathways to externalizing behavior problems in early childhood.

Authors:  Stephanie A Godleski; Shannon Shisler; Rina D Eiden; Marilyn A Huestis
Journal:  Neurotoxicol Teratol       Date:  2018-08-04       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.